Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot study.

ABSTRACT: In order to evaluate the therapeutic potential of fluoxetine in pulmonary arterial hypertension, 13 patients with pulmonary arterial hypertension underwent catheterization before and after 12 (N = 5) or 24 (N = 8) weeks fluoxetine therapy. No change was seen in the primary endpoint of pulmonary vascular resistance, other hemodynamic values, or any secondary endpoints.

SUBMITTER: Sodimu A 

PROVIDER: S-EPMC7691907 | biostudies-literature | 2020 Oct-Dec

REPOSITORIES: biostudies-literature